Investing.com -- Sanofi SA (EPA:SASY) announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application of tolebrutinib, which was ...
Under President Donald Trump, the United States is seeking to create a world order based solely on spheres of interest controlled by the US, China, and Russia. And because this will require breaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback